Reaction to this week's political shocks, why many conservatives are choosing to double down on Trump critics, and then, a conversation on the growing dis-union in America.
The Food and Drug Administration’s approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug’s medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.
- Maxine Klane Planned Parenthood of Metropolitan Washington
- Dr. Mitchell Creinin Physician
- Richard Pierce Professor of administrative law at George Washington University
Most Recent Shows
Political fallout from the dismissal of FBI director James Comey, how our government created racially segregated cities, and a young Palestinian's perspective on Mideast peace.
Washington Post reporter Dan Balz on covering President Trump and linguist Deborah Tannen on how women support each other with the words they use.
American University history professor Allan Lichtman describes how and why President Donald Trump could be impeached, and then, Pulitzer Prize winning writer Elizabeth Strout on her new book, "Anything is Possible".